• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞、细胞疗法和生物工程在肺生物学和疾病中的应用。对 2010-2012 年近期文献的综合回顾。

Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

机构信息

1 University of Vermont College of Medicine, Burlington, Vermont.

出版信息

Ann Am Thorac Soc. 2013 Oct;10(5):S45-97. doi: 10.1513/AnnalsATS.201304-090AW.

DOI:10.1513/AnnalsATS.201304-090AW
PMID:23869446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3960908/
Abstract

A conference, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases," was held July 25 to 28, 2011 at the University of Vermont to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are rapidly expanding areas of study that provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, to discuss and debate current controversies, and to identify future research directions and opportunities for basic and translational research in cell-based therapies for lung diseases. The goal of this article, which accompanies the formal conference report, is to provide a comprehensive review of the published literature in lung regenerative medicine from the last conference report through December 2012.

摘要

一场名为“肺部生物学和肺部疾病中的干细胞和细胞疗法”的会议于 2011 年 7 月 25 日至 28 日在佛蒙特大学举行,旨在回顾目前对于干细胞和祖细胞在损伤后肺部修复中的作用的理解,并回顾细胞疗法和体外生物工程方法在肺部疾病中的应用现状。这些领域是研究的快速扩展领域,为损伤后肺部修复和几种肺部疾病发病机制的传统观点提供了更深入的见解和挑战。会议的目标是总结该领域的现状,讨论和辩论当前的争议,并确定未来的研究方向和机会,以便开展基于细胞的肺部疾病治疗的基础和转化研究。本文是对正式会议报告的补充,旨在对 2011 年会议报告以来至 2012 年 12 月间肺部再生医学领域的已发表文献进行全面综述。

相似文献

1
Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.干细胞、细胞疗法和生物工程在肺生物学和疾病中的应用。对 2010-2012 年近期文献的综合回顾。
Ann Am Thorac Soc. 2013 Oct;10(5):S45-97. doi: 10.1513/AnnalsATS.201304-090AW.
2
An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.美国胸科学会官方研讨会报告:肺生物学与疾病中的干细胞及细胞疗法
Ann Am Thorac Soc. 2015 Apr;12(4):S79-97. doi: 10.1513/AnnalsATS.201502-086ST.
3
Stem cells and cell therapies in lung biology and lung diseases.肺生物学和肺部疾病中的干细胞和细胞疗法。
Proc Am Thorac Soc. 2011 Jun;8(3):223-72. doi: 10.1513/pats.201012-071DW.
4
An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases.2015年美国胸科学会官方研讨会报告。肺生物学与疾病中的干细胞和细胞疗法。
Ann Am Thorac Soc. 2016 Aug;13(8):S259-78. doi: 10.1513/AnnalsATS.201606-466ST.
5
Stem cells and cell therapies in lung biology and diseases: conference report.肺生物学与疾病中的干细胞及细胞疗法:会议报告
Ann Am Thorac Soc. 2013 Oct;10(5):S25-44. doi: 10.1513/AnnalsATS.201304-089AW.
6
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report.《2017 年肺部生物学和疾病中的干细胞、细胞治疗和生物工程》。美国胸科学会官方研讨会报告。
Am J Respir Cell Mol Biol. 2019 Oct;61(4):429-439. doi: 10.1165/rcmb.2019-0286ST.
7
Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023.2023 年肺部生物学和疾病中的干细胞、细胞疗法和生物工程
Am J Physiol Lung Cell Mol Physiol. 2024 Sep 1;327(3):L327-L340. doi: 10.1152/ajplung.00052.2024. Epub 2024 May 21.
8
Stem cells, cell therapies, and bioengineering in lung biology and disease 2021.2021 年肺部生物学和疾病中的干细胞、细胞疗法和生物工程
Am J Physiol Lung Cell Mol Physiol. 2022 Sep 1;323(3):L341-L354. doi: 10.1152/ajplung.00113.2022. Epub 2022 Jun 28.
9
Stem cells and cell therapy approaches in lung biology and diseases.肺生物学和疾病中的干细胞和细胞治疗方法。
Transl Res. 2010 Sep;156(3):188-205. doi: 10.1016/j.trsl.2010.06.007. Epub 2010 Jul 7.
10
Concise review: current status of stem cells and regenerative medicine in lung biology and diseases.简明综述:干细胞与再生医学在肺生物学及疾病中的现状
Stem Cells. 2014 Jan;32(1):16-25. doi: 10.1002/stem.1506.

引用本文的文献

1
Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications.脂肪源性间充质干细胞治疗结缔组织疾病及并发症。
Inflamm Regen. 2024 Jul 19;44(1):35. doi: 10.1186/s41232-024-00348-z.
2
Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023.2023 年肺部生物学和疾病中的干细胞、细胞疗法和生物工程
Am J Physiol Lung Cell Mol Physiol. 2024 Sep 1;327(3):L327-L340. doi: 10.1152/ajplung.00052.2024. Epub 2024 May 21.
3
Endothelial progenitor cells systemic administration alleviates multi-organ senescence by down-regulating USP7/p300 pathway in chronic obstructive pulmonary disease.系统给予内皮祖细胞通过下调慢性阻塞性肺疾病中 USP7/p300 通路缓解多器官衰老。
J Transl Med. 2023 Dec 6;21(1):881. doi: 10.1186/s12967-023-04735-x.
4
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases.阿魏酸:药理学、毒理学和对肺部疾病治疗作用的综述。
Int J Mol Sci. 2023 Apr 28;24(9):8011. doi: 10.3390/ijms24098011.
5
Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis.低分子肝素治疗增强迁移能力和分泌肝细胞生长因子的脂肪间充质干细胞对博来霉素诱导的系统性硬皮病小鼠模型的治疗作用。
Arthritis Res Ther. 2022 Oct 7;24(1):228. doi: 10.1186/s13075-022-02915-6.
6
Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients with pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled study.基于中医证型的综合疗法对尘肺病患者的临床疗效:一项双盲、随机、安慰剂对照的初步研究。
Front Med. 2022 Oct;16(5):736-744. doi: 10.1007/s11684-021-0870-5. Epub 2022 Apr 22.
7
Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside.间充质干细胞在新冠病毒相关肺部疾病中的治疗前景:从实验室到临床应用
World J Stem Cells. 2021 Aug 26;13(8):1058-1071. doi: 10.4252/wjsc.v13.i8.1058.
8
Host Defense against Pneumonia Is Augmented by Lung-Derived Mesenchymal Stem Cells.肺源间充质干细胞增强宿主对肺炎的防御。
J Immunol. 2021 Aug 15;207(4):1112-1127. doi: 10.4049/jimmunol.2000688. Epub 2021 Aug 2.
9
State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery.细胞疗法治疗肺部疾病的最新研究进展,以及气溶胶输送的潜力。
Int J Mol Sci. 2020 Sep 3;21(17):6435. doi: 10.3390/ijms21176435.
10
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report.《2017 年肺部生物学和疾病中的干细胞、细胞治疗和生物工程》。美国胸科学会官方研讨会报告。
Am J Respir Cell Mol Biol. 2019 Oct;61(4):429-439. doi: 10.1165/rcmb.2019-0286ST.

本文引用的文献

1
Stem cells and cell therapies in lung biology and diseases: conference report.肺生物学与疾病中的干细胞及细胞疗法:会议报告
Ann Am Thorac Soc. 2013 Oct;10(5):S25-44. doi: 10.1513/AnnalsATS.201304-089AW.
2
Cell therapy trials for lung diseases: progress and cautions.肺部疾病的细胞治疗试验:进展与注意事项
Am J Respir Crit Care Med. 2013 Jul 15;188(2):123-5. doi: 10.1164/rccm.201302-0351ED.
3
Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.细胞疗法治疗肺部疾病。NIH-NHLBI 研讨会报告,2012 年 11 月 13 日至 14 日。
Am J Respir Crit Care Med. 2013 Aug 1;188(3):370-5. doi: 10.1164/rccm.201303-0522WS.
4
The effect of age and emphysematous and fibrotic injury on the re-cellularization of de-cellularized lungs.年龄、气肿性和纤维性损伤对去细胞化肺再细胞化的影响。
Biomaterials. 2013 Apr;34(13):3256-69. doi: 10.1016/j.biomaterials.2013.01.028. Epub 2013 Feb 4.
5
The effects of storage and sterilization on de-cellularized and re-cellularized whole lung.储存和消毒对去细胞化和再细胞化全肺的影响。
Biomaterials. 2013 Apr;34(13):3231-45. doi: 10.1016/j.biomaterials.2013.01.031. Epub 2013 Feb 4.
6
Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury.人源和鼠源脂肪干细胞在脂多糖诱导的小鼠急性肺损伤模型中的治疗效果比较。
Stem Cell Res Ther. 2013 Jan 29;4(1):13. doi: 10.1186/scrt161.
7
Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.间质干细胞与特发性肺纤维化。临床检测的潜力。
Am J Respir Crit Care Med. 2013 Jul 15;188(2):133-40. doi: 10.1164/rccm.201207-1204PP.
8
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine.意义、概念和重要性:将间充质干细胞科学转化为医学。
Nat Med. 2013 Jan;19(1):35-42. doi: 10.1038/nm.3028. Epub 2013 Jan 7.
9
Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.人骨髓间充质干细胞对活体细菌致体外人肺损伤的治疗作用。
Am J Respir Crit Care Med. 2013 Apr 1;187(7):751-60. doi: 10.1164/rccm.201206-0990OC.
10
Structural integrity, ECM components and immunogenicity of decellularized laryngeal scaffold with preserved cartilage.具有保留软骨的脱细胞喉支架的结构完整性、细胞外基质成分和免疫原性。
Biomaterials. 2013 Feb;34(7):1790-8. doi: 10.1016/j.biomaterials.2012.11.026. Epub 2012 Dec 7.